Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Cell Death and Differentiation|May 5, 2012
miR-205 regulates basement membrane deposition in human prostate: implications for cancer developmentP Gandellini, V Profumo, A Casamichele, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 7, 2017
Pazopanib in advanced germ cell tumors after chemotherapy failure: results of the open-label, single-arm, phase 2 Pazotest trialA Necchi, S Lo Vullo, P Giannatempo, et al.
Investigational New Drugs|February 26, 2014
PF-03446962, a fully-human monoclonal antibody against transforming growth-factor β (TGFβ) receptor ALK1, in pre-treated patients with urothelial cancer: an open label, single-group, phase 2 trialA Necchi, P Giannatempo, L Mariani, et al.
ESMO Open|March 13, 2021
Clinical prognostic factors in advanced epithelioid haemangioendothelioma: a retrospective case series analysis within the Italian Rare Cancers NetworkA M Frezza, A Napolitano, R Miceli, et al.
British Journal of Cancer|November 16, 2013
Analysis of plasma cytokines and angiogenic factors in patients with pretreated urothelial cancer receiving Pazopanib: the role of circulating interleukin-8 to enhance the prognostic accuracyA Necchi, M Pennati, N Zaffaroni, et al.
European Journal of Cancer (Oxford, England : 1990)|October 2, 2014
Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumourS Stacchiotti, M Tortoreto, G G Baldi, et al.
European Journal of Cancer (Oxford, England : 1990)|March 12, 2017
Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumourS Stacchiotti, M Saponara, R Frapolli, et al.
ESMO Open|June 5, 2021
Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of expertsS Stacchiotti, A B Miah, A M Frezza, et al.
Pageof 9